Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

Status:
Terminated

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

This is a trial in obese subjects to study the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of PF-05231023.

Phase 1

Pfizer